Rituximab Does Not Prevent Graft Loss in Renal Transplant Recipients With Chronic Antibody Mediated Rejection With Significant Renal Impairment and Nephrotic Range Proteinuria.

被引：0
|
作者：
Anwar, S. [1 ]
Delos Santos, R. [1 ]
Horwedel, T. [1 ]
Brennan, D. [1 ]
Klein, C. [1 ]
机构：
[1] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A273
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [41] Effectiveness of IVIG Prophylaxis Against Antibody Mediated Rejection in Sensitized Renal Transplant Recipients
    Cyprich, J.
    Biondi, L.
    Cirocco, R.
    Moritz, M.
    TRANSPLANTATION, 2014, 98 : 129 - 129
  • [42] Retrospective Cohort Study Concerning Efficacy and Safety of Bortezomib in Combination With Or Without Rituximab in Antibody Mediated Rejection in Renal Transplant Recipients
    Duerr, M.
    Lachmann, N.
    Budde, K.
    Waiser, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [43] Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients
    Gorden Muduma
    Isaac Odeyemi
    Jayne Smith-Palmer
    Richard F. Pollock
    Advances in Therapy, 2016, 33 : 345 - 356
  • [44] LONGER TERM OUTCOMES FOLLOWING ANTIBODY MEDIATED REJECTION (AbMR) IN RENAL TRANSPLANT RECIPIENTS
    Marcus, Tan
    Fiona, Hudson
    Gemma, Brewin
    Rhonda, Holdsworth
    Solomon, Cohney
    IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (06): : A1 - A2
  • [45] Early Versus Late Acute Antibody-Mediated Rejection in Renal Transplant Recipients
    Dorje, Christina
    Midtvedt, Karsten
    Holdaas, Hallvard
    Naper, Christian
    Strom, Erik H.
    Oyen, Ole
    Leivestad, Torbjorn
    Aronsen, Tommy
    Jenssen, Trond
    Flaa-Johnsen, Linda
    Lindahl, Jorn Petter
    Hartmann, Anders
    Reisaeter, Anna Varberg
    TRANSPLANTATION, 2013, 96 (01) : 79 - 84
  • [46] Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients
    Muduma, Gorden
    Odeyemi, Isaac
    Smith-Palmer, Jayne
    Pollock, Richard F.
    ADVANCES IN THERAPY, 2016, 33 (03) : 345 - 356
  • [47] Rituximab and intravenous immunoglobulin treatment for chronic antibody-mediated renal allograft rejection
    Fehr, T.
    Gaspert, A.
    Ruesi-Elsener, B.
    Weber, M.
    Fischer, A.
    Wuethrich, R. P.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [48] DONOR-SPECIFICITY BUT NOT BROADNESS OF SENSITIZATION IS ASSOCIATED WITH ANTIBODY-MEDIATED REJECTION AND GRAFT LOSS IN RENAL ALLOGRAFT RECIPIENTS
    Wehmeier, Caroline
    Hoenger, Gideon
    Cun, Hasret
    Amico, Patrizia
    Hirt-Minkowski, Patricia
    Georgalis, Argyrios
    Hopfer, Helmut
    Dickenmann, Michael
    Steiger, Jurg
    Schaub, Stefan
    HLA, 2017, 89 (06) : 386 - 386
  • [49] Effectiveness of Rituximab and Intravenous Immunoglobulin for the Treatment of Chronic Antibody Mediated Rejection in Kidney Transplant Recipients.
    An, G.
    Chung, B.
    Park, C.
    Choi, B.
    Kim, Y.
    Yang, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 328 - 328
  • [50] Short and Longer Term Outcomes Following Antibody Mediated Rejection (AbMR) in Renal Transplant Recipients
    Cohney, Shlomo J.
    Wiggins, Kathryn
    Tan, Marcus
    Walker, Rowan
    Hughes, Peter
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 219 - 219
12345